Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2017-2027

LONDON, November 23, 2016 /PRNewswire/ --

Leading IVD Companies in the US, Europe and Asia

What does the future hold for companies of the in vitro diagnostics (IVD) industry? Visiongain's new report Medical Devices Leader Series - Top In Vitro Diagnostics (IVD) Companies 2017-2027: Leading IVD Companies in the US, Europe and Asia shows you the prospects of leading IVD companies to 2027.

Visiongain predicts total revenues the global IVD market will grow from its 2016 level of $61.85bn to $122.9bn by 2027, representing a CAGR of 6.4% during the period 2016 to 2027.

Our report forecasts to 2027 the overarching IVD market and its main segments:
• Point-of-care (POC) tests
• Clinical chemistry
• Immunochemistry
• Haematological diagnostics
• Microbiological applications
• Genetic testing agents
• Other products

This report provides profiles, discussions and financial analyses - including revenue forecasts to 2027 - for top US IVD companies:
• Danaher
• Abbott Laboratories
• Johnson & Johnson (J&J)
• Bio-Rad
• Becton Dickinson
• Thermo Fisher Scientific

Our report shows you developments and revenue forecasts to 2027 for leading diagnostics companies based in Europe:
• Roche
• Siemens
• bioMérieux

This report also provides outlooks and revenue forecasts to 2027 for top Japanesecompanies developing and producing IVD tests:
• Sysmex
• Arkray

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

Our work assesses other companies progressing in that field. There you discover activities of these emerging players and their associated organisations:
• Dako (Agilent Technologies)
• Genomic Health
• Laboratory Corporation of America (LabCorp)
• MDxHealth
• Myriad Genetics
• QIAGEN

Our 185 page report provides 65 tables and 75 figures covering 7 different IVD submarkets, leading companies in the US, Europe and Asia.

Discover the most lucrative areas in the industry and the future market prospects. You will see financial results, industry trends, opportunities, and revenue predictions. The increasing prevalence of both chronic and infectious diseases will ensure that there is a great demand for use and innovation of IVDs over the next decade and beyond.

To request a report overview of this report please emails Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44 (0) 20 7336 6100

Or click on https://www.visiongain.com/Report/1750/Medical-Devices-Leader-Series-Top-In-Vitro-Diagnostics-(IVD)-Companies-2017-2027

List of Companies and Organisation  

3M

AB Sciex

Abbott Laboratories

AbbVie

Accuri Cytometers

Agilent Technologies

Alacris Theranostics GmbH

Alere

Amgen

Analytical Technologies

ARGENE

Arkray

AstraZeneca

Banner Alzheimer's Institute

Bayer

Bayer Diagnostics

BD Pharmaceutical Systems

BD Technologies

Beckman Coulter

Becton, Dickinson and Company (BD)

BioMarin Pharmaceutical

bioMérieux  

Bio-Rad  

Boehringer Ingelheim

Bristol-Myers Squibb

Cancer Research Technology

Cardiogenics

Carmel Pharma AB

Celldex Therapeutics

Cellestis

Centre for Devices and Radiological Health (CDRH)

Cephalon

Claros Diagnostics

Clearstone Central Laboratories

CLIA laboratory

Clovis

Cole-Parmer

Crescendo Bioscience

Dako (Agilent Technologies)

Danaher

Dionex

DxS (Now QIAGEN Manchester)

Eli Lilly

ESE GmbH

Euronext Brussels

European Commission

European Diagnostic Manufacturers Association (EDMA)

European Union (EU)

Explera s.r.l

Fermentas

Fisher Scientific

Food and Drug Administration (US FDA)

Fujirebio

Furuno Electric Co.

Genentech

Genomic Health

GenProbe

Genzyme Genetics

GlaxoSmithKline (GSK)

Hoffman La Roche

Hologic

Ibis Biosciences

IDEXX Laboratories

IGEN International

Illumina

Institut Pasteur

Institute Merieux

Instrumentation Labs

Ipsen

Ipsogen

JEOL Ltd.

John Hopkins University

Johnson & Johnson (J&J)

Katakura Industries

KIESTRA Lab Automation

Knome

LabCorp

Laboratory Corporation of America (LabCorp)

Leica Biosystems

Life Technologies

Luminex

Lyon Civil Hospitals

MDS

MDxHealth

Medco Health Sciences

Merck & Co.

Mindray

Miraca Life Sciences

Monogram Biosciences

Myriad Genetics

Myriad RBM

Nalgene

Newcastle University

Novartis

Oncomed

OncoMethylome

Ortho-Clinical Diagnostics

Pfizer

Phadia

Pierce Protein Research

Polymedco Inc.

QIAGEN

QuantaLife

Quest Diagnostics

Radiometer

Response Biomedical Corporation

Roche

Roche Applied Science

Saladax

Schering Plough

SDIX

Siemens Healthcare

Sirigen Group Limited

STARLIMS Technologies

Surgipath

SWOG

Sysmex Corporation

Sysmex Group

Teva Pharmaceutical Industries

Thermo Fisher Scientific

Thermo Scientific

TOA Corporation

TOA Medical Electronics

Tocagen

Tosoh

Transasia Bio Medicals

Van Andel Research Institute

Ventana

Vermillion

ViiV Healthcare

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com